Arrowstreet Capital Limited Partnership Increases Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Arrowstreet Capital Limited Partnership boosted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 121.9% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 142,441 shares of the company's stock after acquiring an additional 78,240 shares during the quarter. Arrowstreet Capital Limited Partnership owned about 0.08% of Option Care Health worth $3,305,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Murphy & Mullick Capital Management Corp bought a new position in shares of Option Care Health during the 4th quarter valued at approximately $26,000. UMB Bank n.a. increased its position in Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares during the last quarter. Signaturefd LLC raised its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after acquiring an additional 1,005 shares during the period. Blue Trust Inc. lifted its holdings in shares of Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock worth $109,000 after acquiring an additional 681 shares during the last quarter. Finally, Venturi Wealth Management LLC grew its holdings in Option Care Health by 2,621.3% during the 4th quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock valued at $110,000 after purchasing an additional 4,561 shares during the last quarter. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Remove Ads

Option Care Health Stock Up 0.8 %

Shares of OPCH traded up $0.24 during mid-day trading on Monday, hitting $31.79. The company's stock had a trading volume of 86,313 shares, compared to its average volume of 1,771,602. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The company's 50-day moving average is $33.24 and its 200-day moving average is $28.58. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The firm has a market capitalization of $5.22 billion, a price-to-earnings ratio of 26.69, a PEG ratio of 2.30 and a beta of 1.07.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. 0.64% of the stock is owned by company insiders.

Analysts Set New Price Targets

OPCH has been the subject of several recent analyst reports. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. increased their target price on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. JMP Securities reissued a "market outperform" rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Barrington Research lifted their price objective on shares of Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a report on Thursday, February 27th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.